middle.news
How Cyclopharm’s Technegas Won NIH Approval and What It Means for US Growth
12:52pm on Wednesday 18th of February, 2026 AEDT
•
Healthcare
Read Story
How Cyclopharm’s Technegas Won NIH Approval and What It Means for US Growth
12:52pm on Wednesday 18th of February, 2026 AEDT
Key Points
Technegas approved for clinical use at US NIH
Installation expected soon following purchase order
Leverages five-year Federal Supply Schedule agreement
Supports expanded use beyond pulmonary embolism
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cyclopharm (ASX:CYC)
OPEN ARTICLE